<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">354041</id>
  <title nil="true"/>
  <common-name>3-[1-[1-[(4-methylpiperidin-1-yl)methyl]benzimidazol-2-yl]-2-phenylethyl]-2-phenylquinazolin-4-one</common-name>
  <description>3-[1-[1-[(4-methylpiperidin-1-yl)methyl]benzimidazol-2-yl]-2-phenylethyl]-2-phenylquinazolin-4-one is a chemical compound with the formula C36H35N5O. With an average molecular weight of 553.70 g/mol, 3-[1-[1-[(4-methylpiperidin-1-yl)methyl]benzimidazol-2-yl]-2-phenylethyl]-2-phenylquinazolin-4-one is a heavy molecule.</description>
  <cas>91045-33-9</cas>
  <pubchem-id>63651</pubchem-id>
  <chemical-formula>C36H35N5O</chemical-formula>
  <weight>553.7</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T21:19:31Z</created-at>
  <updated-at type="dateTime">2026-08-31T21:19:31Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC1CCN(CC1)CN2C3=CC=CC=C3N=C2C(CC4=CC=CC=C4)N5C(=NC6=CC=CC=C6C5=O)C7=CC=CC=C7</moldb-smiles>
  <moldb-formula>C36H35N5O</moldb-formula>
  <moldb-inchi>InChI=1S/C36H35N5O/c1-26-20-22-39(23-21-26)25-40-32-19-11-10-18-31(32)38-35(40)33(24-27-12-4-2-5-13-27)41-34(28-14-6-3-7-15-28)37-30-17-9-8-16-29(30)36(41)42/h2-19,26,33H,20-25H2,1H3</moldb-inchi>
  <moldb-inchikey>RQUFQMLAALMVFQ-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">553.2841608</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>6.9</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM349934</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>3-[1-[1-[(4-methylpiperidin-1-yl)methyl]benzimidazol-2-yl]-2-phenylethyl]-2-phenylquinazolin-4-one</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Diazanaphthalenes</klass>
  <subklass>Benzodiazines</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0304323</sync-id>
  <structure-inchikey>RQUFQMLAALMVFQ-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>40000000000400000001800000100001000001008000000000000000000000000000000040008020000000000400002004000000000000000000000000200080000000000000002000000000000000000020000000000000000000008000000000000100200000000000004200000000000000020100400000040000000000100000000040200000804000000000000800800000000100000000000000040000040000040004000000050000080000000000000000000020008000000000000000000000040000000000000000000000001000000000002005000220020020010000000000040001000040000000008000000000000000000000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>7014c00085128670c1805b6481b8a2201a10148085052070803f20408234e9cc6c222051138000001108492844c0000004600327408d3225096ee57980a1c010c7110c891ed074004090134012720280080485f153211f3342041d62542258046c28052f184c3221614ca491dd94024d208680708521c50631192c6c02511216104d19094efa820809870250ce2c0288b91d989244069e8b5423182064c004a401d3101780baca300a040d68017c3d144ac00402a941084818b06a386cc0423ab09010e4449903331d818680775152d90d410010034050608d6102c42a2003049138493018892b2013480411d912a0a20850043090c6842e5100900072190a02</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAqAAAAMAAAAIABBgBgAAAAAQMGAGAAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:51:52Z</structure-indexed-at>
</compound>
